title: Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity.
abstract: Blastocyst-derived pluripotent embryonic stem (ES) cells of the mouse can be induced to differentiate in culture into a variety of cell types, including cardiac muscle cells. The embryonic stem cell test that makes use of the differentiation of ES cells into cardiomyocytes in a standardized in vitro model was developed to offer an alternative method to comprehensive in vivo studies in reproductive toxicology about toxic effects of chemicals. ES cells of the mouse cell line D3 are investigated for their preserved capability to differentiate following drug exposure, and both ES cells and differentiated fibroblast cells of the mouse cell line 3T3 are comparatively analyzed for effects on viability. The following endpoints are used to classify the embryotoxic potential of chemicals into three classes of in vitro embryotoxicity (non-, weakly or strongly embryotoxic). These endpoints are: (1) the inhibition of differentiation of ES cells into cardiomyocytes after 10 days of treatment, and the decrease of viability (cytotoxicity) of (2) 3T3 cells and (3) ES cells after 10 days of treatment, determined by a 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT) test. 50% inhibition concentrations for differentiation (ID(50)) and cytotoxicity (IC(50)D3 and IC(50)3T3) are calculated from concentration-response curves. Applying linear analysis of discriminance, a biostatistical prediction model (PM) was developed. This procedure identified three variables, the lg(IC(50)D3), the lg(IC(50)3T3) and the relative distance between IC(50)3T3 and ID(50), that improved the separation of the three classes of embryotoxicity compared to the prediction model that was originally proposed after test development. Unlike the original PM, the improved PM incorporates as one variable the relative distance between IC(50)3T3 and ID(50), instead of the ratio ID(50)/IC(50)D3 that was used previously.
authors.affiliation: Center for Documentation and Evaluation of Alternative Methods to Animal Experiments (ZEBET), Berlin, Germany. zebet@bgvv.de
authors.forename: G
authors.initials: G
authors.lastname: Scholz
authors.forename: I
authors.initials: I
authors.lastname: Pohl
authors.forename: E
authors.initials: E
authors.lastname: Genschow
authors.forename: M
authors.initials: M
authors.lastname: Klemm
authors.forename: H
authors.initials: H
authors.lastname: Spielmann
mesh_terms: D000818:Animals; D003114:Colony-Forming Units Assay; D005333:Fetus / Q000166:cytology; D051379:Mice; D013234:Stem Cells / Q000187:drug effects*; D013723:Teratogens / Q000633:toxicity*; D018675:Toxicity Tests
chemical_list: D013723:Teratogens